Skip to main content
SpringerLink
Log in

HCV patients with CKD have higher healthcare costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

Reference

  • Puenpatom A, et al. Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens. Clinical Drug Investigation : 6 Apr 2017. Available from: URL: http://doi.org/10.1007/s40261-017-0526-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HCV patients with CKD have higher healthcare costs. PharmacoEcon Outcomes News 776, 21 (2017). https://doi.org/10.1007/s40274-017-3923-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3923-x

Search

Navigation